LEADS BIOLABS-B (09887) Included in Hang Seng Composite Index and Added to Stock Connect List

Stock News03-06

LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and added to the list of eligible securities for the Southbound Stock Connect program. The inclusion in both the Hang Seng Composite Index and the Stock Connect program represents significant recognition from the capital markets regarding the company's performance and value. It will permit qualified mainland Chinese investors to directly invest in the shares, which are listed on the Hong Kong Stock Exchange, through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect mechanisms. This inclusion is anticipated to broaden the company's investor base, enhance the trading liquidity of its shares, and further optimize the shareholder structure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment